Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2537133 | European Journal of Pharmacology | 2006 | 7 Pages |
Abstract
This study examined the effects on orofacial movement topography of SK&F 83822 ([R/S]-6-chloro-7,8-dihydroxy-3-allyl-1-[3-methylphenyl]-2,3,4,5-tetrahydro-1H-3-benzazepine), which stimulates dopamine D1-like receptors coupled to stimulation of adenylyl cyclase (AC) but not phosphoinositide (PI) hydrolysis, in comparison with SK&F 83959 ([R/S]-3-methyl-6-chloro-7,8-dihydroxy-1-[3-methyl-phenyl]-2,3,4,5-tetrahydro-1H-3-benzazepine), which stimulates PI hydrolysis but not AC. SK&F 83822 alone induced chattering, while SK&F 83959 alone exerted little effect. SK&F 83822 and SK&F 83959 each in combination with the dopamine D2-like agonist quinpirole resulted in synergistic induction of non-chattering movements with tongue protrusions. These effects were blocked by the dopamine D1-like receptor antagonist SCH 23390 ([R]-3-methyl-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine). However, the dopamine D2-like receptor antagonist YM 09151-2 (cis-N-[1-benzyl-2-methyl-pyrrolidin-3-yl]-5-chloro-2-methoxy-4-methylaminobenzamide) exerted a biphasic effect on synergism with SK&F 83822: chattering was initially released but antagonised thereafter. Only antagonism was seen for synergism with SK&F 83959. While both AC- and PI-coupled dopamine D1-like receptors participate in synergistic dopamine D1-like:D2-like receptor interactions, topographically specific synergistic and oppositional dopamine D1-like:D2-like interactions evident with SK&F 83822 reflect the involvement primarily of D1-like receptors coupled to AC rather than PI.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Satoshi Fujita, Jun Lee, Motori Kiguchi, Takuya Uchida, Alexander R. Cools, John L. Waddington, Noriaki Koshikawa,